Buy or sell Mammoth Biosciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Mammoth Biosciences Stock

Mammoth Biosciences is the CRISPR platform for diagnostics.

Founded

2017

Headquarters

San Francisco CA, US

About Mammoth Biosciences Stock

Mammoth Diagnostics is the CRISPR data platform for diagnostics. Mammoth Diagnostics is trying to create a new class of rapid, low cost, and easy-to-use diagnostics for industries ranging from oil and gas to agriculture to healthcare.

Management

Co-Founder, CTO

Ashley Tehranchi

Co-Founder, CEO

Trevor Martin

Co-Founder, Chief Discovery Officer

Lucas Harrington

Co-Founder, Chief Research Officer

Janice Chen

Co-Founder

Jennifer A. Doudna

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Mammoth Biosciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo